Project Details
Description
The cognitive and behavioral symptoms that characterize Alzheimer’s disease (AD) are thought to result from impaired communication between neurons in the brain at connections called synapses. Toxic forms of a protein called tau play a central role in AD and other neurodegenerative conditions, and recent data show that tau can interfere with synapses in multiple ways. These observations greatly underscore efforts to treat AD by blocking the pathological actions of tau. The goal of this project is to better understand how tau interferes with synaptic function so that we can develop effective strategies to block the impairments it causes.
Status | Finished |
---|---|
Effective start/end date | 7/1/17 → 6/30/21 |
Funding
- BrightFocus Foundation: US$300,000.00
ASJC Scopus Subject Areas
- Clinical Neurology
- Ophthalmology
- Neurology
- Medicine(all)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.